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THE GOOD, THE BAD, AND THE
UGLY:  DRUG TESTING BY
EMPLOYERS IN ALASKA
This Note examines Alaska’s 1997 Drug and Alcohol Testing by
Employers statute.  It first performs a brief overview of the legal
implications of employer drug testing.  Next it examines Alaska’s
Act from the perspectives of both employers and employees.  The
Note then considers similar drug testing legislation on the state
and federal level and provides a brief description of the political
climate that has led to the abundance of legislation on drug
testing.  It concludes that the perceived workplace drug crisis
prompting such legislation rests on faulty premises and should be
reconsidered.
History teaches that grave threats to liberty often come in times of
urgency, when constitutional rights seem too extravagant to
endure.  The World War II relocation camp cases, and the Red
scare and McCarthy-era internal subversion cases are only the
most extreme reminders that when we allow fundamental
freedoms to be sacrificed in the name of real or perceived
exigency, we invariably come to regret it.
— Justice Thurgood Marshall1
I.  INTRODUCTION
In September 1997, the Alaska Legislature joined a growing
number of states when it passed legislation designed to facilitate
the use of employment drug testing by private employers.  The
Drug and Alcohol Testing by Employers statute, Alaska Statutes
sections 23.10.600-23.10.6992 (the “Act”), provides guidelines for
drug testing procedures,3 while protecting employers from liability
for both adverse employment actions taken on the basis of drug
Copyright © 1999 by Mechelle Zarou.  This Note is also available on the World
Wide Web at http://www.law.duke.edu/journals/16ALRZarou.
1. Skinner v. Railway Labor Executives’ Ass’n, 489 U.S. 602, 635 (1989)
(Marshall, J. dissenting) (upholding federal regulations mandating drug testing for
railroad employees) (internal citations omitted).
2. See ALASKA STAT. §§ 23.10.600-99 (LEXIS 1998).
3. See id. § 23.10.640.
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testing results4 and inappropriate disclosure of an employee’s
confidential information.5  The employer is entitled to the
protections of the Act as long as the specified procedures are
followed.6  The statute allows employers to drug test for any job-
related purpose consistent with business necessity.7  Although
compliance with the Act is voluntary,8 the protections embedded
within it provide indisputable incentives for private employers to
undertake drug testing of all employees.
Although the Alaska Legislature failed to provide a section
detailing the purpose of the statute or the underlying findings upon
which the statute is based, it seems clear that an increase in the
number of Alaskan private employers conducting drug tests is one
of the desired results.  Like similar statutes in Utah9 and Arizona,10
the Alaska statute was based on the President’s Commission on
Model State Drug laws.11  Both Utah and Arizona provide a
statement of legislative intent.  The Utah Legislature states that
[t]he abuse of drugs and alcohol creates a variety of workplace
problems . . . .  Therefore, in balancing the interests of
employers, employees, and the welfare of the general public, the
Legislature finds that fair and equitable testing for drugs and
alcohol in the workplace, in accordance with this chapter, is in
the best interest of all parties.12
The Arizona Legislature indicated that “[t]he abuse of illegal drugs
and alcohol is a matter of substantial public concern.  The intent of
the Legislature in this Act is to encourage the development of
uniform standards and requirements regarding the testing of
employees and prospective employees for use of such substances in
the work setting.”13  The goal of the Utah, the Arizona, and, by
analogy, the Alaska statute is thus not only to encourage drug
4. See id. § 23.10.600.
5. See id. § 23.10.610.
6. See id. § 23.10.640.
7. See id. § 23.10.620(c).
8. See id. § 23.10.615.
9. See UTAH CODE ANN. §§ 34-38-1 to 15 (1998).
10. See ARIZ. REV. STAT. ANN. §§ 23-493.01 to 11 (West 1995).
11. See Cutting Edge Issues in Drug Treatment and Testing:  Hearings on H.R.
3853 Before the Subcomm. on Nat’l Security, Int’l Affairs and Criminal Justice of
the Comm. on Bov’t Reform and Oversight, 105th Cong. (1998) (statement of
Mark de Bernardo, Executive Director, Institute for a Drug-Free Workplace)
[hereinafter Hearings] (noting that the legislation endorsed by the President’s
Commission on Model State Drug Laws was enacted into law in Alaska, Arizona,
Idaho, and Utah).
12. UTAH CODE ANN. § 34-38-1 (1998).
13. 1994 Ariz. Legis. Serv. 246 § 1 (West).
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testing by shielding employers from litigation, but also to ensure
that the drug testing performed on employees is equitable and
based on uniform standards.  The drug testing statutes provide the
strongest protection to employers, but also protect employees by
requiring employers to comply with fair and standard testing
procedures, thus limiting the opportunity for abuse of discretion by
employers.14
Part II of this Note will analyze the Alaska drug testing statute
by providing a brief overview of the legal implications of
employment drug testing, including contract, tort, and common law
claims.  Part III will examine the Act from the perspectives of both
employers and employees.  This consideration will include the
requirements imposed by the statute, the protections provided if
these requirements are met, and the potential problems this statute
causes both employers and employees.
Part IV will examine similar drug testing legislation on the
state and federal level.  In Part V, this Note will provide a brief
description of the political climate that has led to so much
legislation on workplace drug testing, ultimately concluding that
the perceived workplace drug crisis prompting such legislation rests
on faulty premises and should be fundamentally reconsidered
before further measures are passed.
II.  LEGAL CHALLENGES TO DRUG TESTING
Both the United States Constitution and the Alaska
Constitution protect an individual’s right to privacy.  The U.S.
Constitution provides this protection in the penumbra of the Bill of
Rights,15 while the Alaska Constitution explicitly guarantees the
right to privacy in Article I, Section 22: “Right of Privacy.  The
right of the people to privacy is recognized and shall not be
infringed.”16  The U.S. Constitution has been interpreted to govern
only state action,17 except for the Thirteenth Amendment’s
prohibition of slavery, which also applies to private action.18  The
14. See id.; see also ALASKA STAT. § 23.10.640 (LEXIS 1998); ARIZ. REV.
STAT. ANN. § 23-493.03 (West 1995); UTAH CODE ANN. § 34-38-1, § 34-38-6
(1998).
15. See U.S. CONST. amends. I-X.
16. ALASKA CONST.  art. I, § 22.
17. See Skinner v. Railway Labor Executive Ass’n, 489 U.S. 602, 614 (1989)
(noting that “the Fourth Amendment does not apply to a search or seizure, even
an arbitrary one, effected by a private party on his own initiative.”).
18. See U.S. CONST. amend. XIII; see also Clyatt v. United States, 197 U.S. 207
(1905), cited in Luedtke v. Nabors Alaska Drilling, Inc., 768 P.2d 1123, 1130
(1989).
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Alaska Constitution also has been interpreted to apply to state
action.19  In Luedtke v. Nabors Alaska Drilling, Inc.,20 the Alaska
Supreme Court declined to extend the constitutional right to
privacy to the actions of private parties.21  Thus, neither
constitution protects the privacy rights of employees in the private
sector who are subject to drug testing.
The Alaska Supreme Court’s decision in Luedtke is notable,
however, for establishing “a public policy protecting spheres of
employee conduct into which employers may not intrude.”22  The
court noted that “the citizen’s right to be protected against
unwarranted intrusions into their private lives has been recognized
in the law of Alaska.  The constitution protects against
governmental intrusion, statutes protect against employer
intrusion, and the common law protects against intrusions by other
private persons.”23  Alaska also recognizes a covenant of good faith
and fair dealing in employment contracts for at-will employees,24
which can be breached by an employer’s violation of public policy.25
However, the court failed to find that this public policy protecting
employee privacy is violated by employer monitoring of employee
drug use occurring outside the workplace.26
In Luedtke, the court upheld an employer’s discharge of two
employees for refusing to submit to a drug test, holding that the
employer’s safety interest outweighed the employees’ right to
privacy.27  The Luedtke court did place restrictions on drug testing,
19. See United Jaycees v. Richardet, 666 P.2d 1008 (Alaska 1983) (equal
protection and civil rights); Woods & Rhode, Inc. v. State, Dep’t of Labor, 565
P.2d 138 (Alaska 1977) (unreasonable search and seizure); Ravin v. State, 537
P.2d 494 (Alaska 1975) (right to privacy in Alaska).  These cases were all cited in
Luedtke, 768 P.2d at 1129-30.
20. 768 P.2d 1123 (Alaska 1989).
21. See id. at 1130.
22. Id. at 1133.
23. Id.
24. See Mitford v. de LaSala, 666 P.2d 1000 (Alaska 1983).
25. See Knight v. American Guard & Alert, Inc., 714 P.2d 788, 792 (Alaska
1986) (“We have never rejected the public policy theory.  Indeed, it seems that the
public policy approach is largely encompassed within the implied covenant of
good faith and fair dealing which we accepted in Mitford.”).
26. See Luedtke, 768 P.2d at 1133.
27. See id. at 1137.  An important factor for the court was the extreme danger
inherent in oil rig work.  In a less dangerous industry, the employer’s safety
concerns may not have taken precedence over the employee’s right to privacy.
An unresolved question is how Alaska Statutes sections 23.10.600-99 will affect
the analysis of a breach of the implied covenant of good faith and fair dealing in
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however, requiring that the test be conducted at a time reasonably
contemporaneous with work time and that employees receive
notice of the adoption of a drug testing program.28  Because one of
the discharged employees was initially suspended for a drug test
taken prior to the employer’s announcement of its drug testing
program,29 the court remanded for a determination of whether his
suspension breached the covenant of good faith and fair dealing for
lack of notice.30  In addition, the court found that the employer did
not commit the common law tort of invasion of privacy when it
drug tested the employees, since the test was not conducted in an
unreasonable manner nor for an unwarranted purpose.31
The Alaska Supreme Court in Luedtke has thus upheld drug
testing in the face of constitutional, contract, and common law
challenges.  However, the Luedtke court did not face the issue of
how federal discrimination laws impact employment drug testing.
Thus far, no court has addressed the interplay of the Americans
with Disabilities Act (“ADA”)32 with an Alaskan employer’s
decision to drug test.  While the ADA explicitly allows employer
drug testing by indicating that drug testing is not a prohibited
medical exam,33 it does restrict employers’ use of confidential
employee medical information.34  Thus, although the ADA may not
serve as a bar to drug testing, it can provide an important
protection to employees concerned about the ramifications of
providing employers with urine or other samples for drug testing,
the drug testing context, and whether the public policy protecting employee
privacy will be damaged because of these sections of the statute.
28. See id. at 1136-37.  These requirements were eventually included in the
Alaska Legislature’s adoption of sections 23.10.600-99.  See infra notes 38-45 and
accompanying text.
29. See Luedtke, 768 P.2d at 1125-26.
30. See id. at 1137.
31. See id.  The court concluded that the test was not performed in an
unreasonable manner because the employee voluntarily provided the sample,
despite the fact that he did not know it would be tested for illegal drugs.  The
court also concluded that the test was not performed for an unwarranted purpose
because the court had already determined that the employer’s safety interest was
a legitimate purpose.
32. Americans with Disabilities Act of 1990, 42 U.S.C. § 12111 et seq. (1994).
33. See id. § 12114(d)(1).
34. See id. § 12112(d)(3)(c); see also Roe v. Cheyenne Mountain Conf. Resort,
Inc., 124 F.3d 1221 (10th Cir. 1997) (upholding summary judgment for employee
on claim that employer’s required disclosure of prescription drug usage in relation
to drug testing violated section 12112(d)(4) of the ADA).  The disclosures in
Cheyenne Mountain had to be “reported and approved by an employee
supervisor.”  Id. at 1226.
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as well as the disclosures of confidential medical information that
typically accompany drug testing.
III.  STATUTORY EXPLANATION
Since the courts have paved the way for more private
employers to establish drug testing programs, it was inevitable that
state legislatures would soon follow.  In enacting this drug testing
statute, the Alaska legislature recognized the potential for abuse in
conducting employment drug testing, and provided guidelines to
employers on conducting such tests.  However, the Alaska
Legislature was also faced with a risk-free opportunity to
demonstrate a “tough on drugs” position without costing taxpayers
a penny.35  Any costs associated with drug testing are borne by the
employers themselves, and because employer compliance is
voluntary, there are no enforcement or regulatory costs.  In
addition, the interests of the business community in achieving a
safe workplace, preventing absenteeism, mitigating insurance costs,
and avoiding association with drug users are well served by
allowing more employers to implement drug testing without the
threat of litigation.  However, the Act fails to provide employees
with equally valuable protections,36 and fails employers in some
important respects as well.37  The Alaska Legislature missed a rare
opportunity to pass legislation that satisfies the needs of a large
cross-section of their constituency, both employers and employees,
when it omitted many provisions that could have made the Act a
more valuable statute.
A. The Employer’s View of Alaska Statutes Sections 23.10.600-99
1. Employer Requirements.  In order for employers to receive
the vast array of protections provided by the Act, they must
35. Legislative testimony on the proposed Private Sector Drug-Free
Workplace Act, the Federal counterpart to the Act, is instructive here.  See
generally Hearings, supra note 11 (Mr. de Bernardo cites one of the benefits of the
Private Sector Drug-Free Workplace Act as the fact that it is “revenue neutral. . . .
This bill would not cost the taxpayers a dollar. . . . There is no need for
government regulation and enforcement since the process is self-policing, an
employer who does not comply simply would be subject to potential legal
liability.”).  See also infra notes 171-180 and accompanying text (discussing the
proposed Private Sector Drug-Free Workplace Act).
36. See infra notes 102-131 and accompanying text (highlighting employee
problems with the Act).
37. See infra notes 86-94 and accompanying text (highlighting employer
problems with the Act).
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comply with both the extensive administrative requirements38 and
the stringent testing procedures39 set out in the statute.  Before
initiating a drug-testing program, the Act requires employers to
establish a written policy at least thirty days prior to the start of the
program.40  The employer must distribute the written policy to
employees or ensure that it is available in a personnel handbook,
manual, or posting.41  At a minimum, the written policy must
include the following: (1) the employer’s policy on employee drug
and alcohol use; (2) a description of those employees subject to
testing; (3) the circumstances under which testing may be required;
(4) the substances for which tests will be conducted; (5) a
description of the testing methods and procedures to be used; (6)
the consequences of a refusal to participate in testing; (7) the
adverse personnel action that may be taken based on the results of
the testing; (8) the employee’s right to obtain written test results
and the employer’s obligation to provide those results within five
working days, so long as the request is within six months of the
testing date; (9) the employee’s right to explain, upon employee’s
request and in a confidential setting, a positive test result; and (10)
the employer’s policy regarding the confidentiality of the test
results.42
There are many requirements governing the testing
procedures and sample collection that employers must meet in
order to receive the Act’s shield from litigation.43  Drug testing
required by the employer must be scheduled during, immediately
before, or immediately after a regular work period, and the time
taken for testing must be considered work time for the purposes of
compensation and benefits.44  In addition, the employer must pay
the entire cost of the drug test and for reasonable transportation
costs to the testing site if the test is not conducted at the
employee’s normal work site.45  The employer must ensure that
sample is collected “in a manner that guarantees the individual’s
privacy to the maximum extent consistent with ensuring that the
sample is not contaminated, adulterated, or misidentified.”46
Although the employer may designate the type of sample to be
38. See ALASKA STAT. § 23.10.620 (LEXIS 1998).
39. See id. §§ 23.10.630-50.
40. See id. § 23.10.620(e).
41. See id. § 23.10.620(a).
42. See id. § 23.10.620(b).
43. See id. §§ 23.10.630-50.
44. See id. § 23.10.630(c).
45. See id. § 23.10.630(d).
46. Id. § 23.10.630(c).
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used for testing,47 the statute defines “sample” as “urine or breath
from the person being tested.”48  It is uncertain whether the Act
will protect employers who conduct drug testing based on analysis
of hair, sweat, or saliva.49
To receive the protections of the Act, employers must conduct
the drug testing at a laboratory approved or certified by the
Substance Abuse and Mental Health Services Administration (or
the College of American Pathologists, American Association of
Clinical Chemists), and the testing must comply with scientifically
accepted analytical methods and procedures.50  The samples must
be fully documented, collected, stored, and transferred in a manner
reasonably designed to prevent misidentification, contamination,
or adulteration.51  The person tested must have an opportunity to
provide medical information relevant to the test, including
identification of prescription and non-prescription drugs that might
affect the outcome of the test.52
The Act further requires confirmation of a positive test result
by a different analytical process than that used in the first test.53
The statute provides that the second, or confirmatory, test must be
the more expensive gas chromatography/mass spectrometry
method.54  Positive confirmatory results must also be reviewed by a
47. See id. § 23.10.630(a).
48. Id. § 23.10.699(9).
49. Although these methods of testing are somewhat less intrusive than urine
testing, they are more controversial because dark hairs tend to absorb more drugs
than lighter hairs when the same amounts of drugs are consumed.  See Federal
Workplace Drug Testing: U.S. House of Representatives Comm. on Commerce,
Subcomm. on Oversight and Investigations, Dept. of Health and Human Services
Policy on Drug Testing Panel 1, 105th Cong. (1998) (statement of Carl M. Selavka,
Ph.D., Consulting Scientist to Dept. of Health and Human Services Drug Testing
Advisory Board [hereinafter Federal Workplace Drug Testing]. Dr. Selavka also
served as consultant to review and summarize data provided by hair, sweat, and
saliva drug testing proponents.).
50. See ALASKA STAT. § 23.10.640(c).
51. See id. § 23.10.640(a).
52. See id.
53. See id. § 23.10.640(d).
54. See id.  This form of test is generally considered more reliable than
immunoassays, the most widely used method in workplace drug testing.  See
Steven Hecker, Technical Issues and Procedural Safeguards in Workplace Drug
Testing, 7 LERC MONGRAPH SER. 52, 54-57 (“[p]roperly done, the [gas
chromatography/mass spectrometry] provides the most conclusive identification of
all the urine screening techniques.  However, it relies on expensive equipment,
highly trained technicians, and is quite expensive.”).  Immunoassays are attractive
to employers because they can be:
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licensed physician or doctor of osteopathy, often referred to in the
Act as a Medical Review Officer (“MRO”).55  The MRO’s
responsibilities include contacting employees within forty-eight
hours of testing, offering to discuss positive test results, interpreting
and evaluating the test results for legal use, and reporting results
caused by prescription medicine as negative results.56  Although the
statute does not address the costs associated with the MRO’s
duties, it appears that they must be borne by the employer.  To aid
in the determination of whether reasonable suspicion exists to
require an individual employee to undergo testing, employers must
train at least one employee for sixty minutes on alcohol misuse and
sixty minutes on use of controlled substances.57  Finally, if an
employer decides to test for drugs for which the United States
Department of Health and Human Services (“HHS”) has already
established a cutoff level, then a test will be considered positive if
the employee’s sample is greater than or equal to that cutoff level.58
If the test is for a drug for which no cutoff level has been
established, the employer must inform employees in the written
policy of the cutoff level that will be used.59
If employers opt to conduct on-site drug testing,60 they assume
more extensive commitments to fairness and objectivity than if
they conducted off-site testing.  They must use testing products
approved by the Food and Drug Administration (“FDA”), and
these products must be used in accordance with the manufacturer’s
instructions.61  The testing must be administered by someone who
has been trained in person by the manufacturer of the test and
highly automated and hence are quite inexpensive, costing as little as $10
per sample. . . The very principle of these tests, however, raises some
problems.  Since the tests depend on the binding of an antibody to the
drug, other substances which compete with the drug for the antibody,
including legal medications, food metabolites, or the body’s own
enzymes, may cause false results.  This cross-reactivity necessitates that
positive immunoassay results be confirmed by an independent
procedure.
Id. at 55.
55. See ALASKA STAT. § 23.10.640(d).
56. See id.
57. See id. § 23.10.650(a).  The designation of this individual implies that when
drug testing is based on reasonable suspicion, this individual’s training will be
utilized to determine who will be tested.  However, this does not indicate that
drug testing will be based on reasonable suspicion in all cases.
58. See id. § 23.10.640(e).
59. See id.
60. See id. § 23.10.645(a).
61. See id.
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certified by that manufacturer as competent to administer the test.62
Additionally, the administrator of on-site drug tests must be
trained to recognize adulteration of a sample and sign a statement
that he or she will hold all information related to drug testing
confidential.63  The Act also requires that the administrator of an
on-site test allow the employee to observe both the testing
procedure and the results, and must keep the test sample in the
employee’s sight at all times.64  The employer may not take
permanent employment action based on an unconfirmed on-site
positive result.65  If the employer takes temporary adverse
employment action on this basis, the employer must restore the
employee’s wages and benefits if the confirmatory test is negative.66
Throughout the testing process and the resulting action,
employers may not disclose any information regarding drug test
results to anyone other than the tested employee, those designated
by the employee to receive the information, those designated by
the employer to receive and evaluate test results, or as ordered by a
court or governmental agency.67  The employer bears the burden of
ensuring confidentiality of results and records of drug tests.
However, because the protections offered to employers by the Act
are not jeopardized by breaches of confidentiality,68 employers
have less incentive to comply with this provision than with the
other requirements of the statute.
The extensive administrative requirements,69 specified testing
procedures,70 and increased financial burden71 posed by the Act
may discourage employers from complying with its provisions, even
at the risk of litigation over drug testing.  While this statute may
provide great benefits to employers, it is clear that these benefits
do not come without substantial costs.
62. See id. § 23.10.650(b).
63. See id.
64. See id. § 23.10.645(b).
65. See id. § 23.10.645(c).
66. See id.
67. See id. § 23.10.660.
68. See id. §§ 23.10.600-10.  Disclosures of confidential information to
unauthorized individuals are not actionable unless stringent conditions are met.
See also infra notes 117-127 and accompanying text (detailing disclosure
provisions).
69. See ALASKA STAT. § 23.10.620; see also supra notes 38-42 and
accompanying text.
70. See ALASKA STAT. §§ 23.10.630-50; see also supra notes 43-59 and
accompanying text.
71. See id.
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2. Employer Protections.  Employers who comply with the
many requirements of the statute discussed above will be protected
from an action for damages for the following: (1) actions in good
faith based on a positive drug test result;72 (2) failure to test for
drugs or alcohol impairment; (3) failure to test or detect a specific
drug, other substance or medical condition (including mental and
emotional disorders); and (4) termination or suspension of drug
testing policy.73  Employers are also protected from actions for
damages related to the employer’s action, or inaction, with respect
to a “false negative” test, that is, a test of an employee who uses
drugs but produces a mistakenly negative drug test result.74  Finally,
employers are protected from actions for failure to establish a
substance abuse prevention program or to implement drug
testing.75
The statute provides a further protection by severely limiting
the legal recourse of employees who suffer an adverse employment
action or whose confidential test results are disclosed when the
drug test results constitute a “false positive,” a drug test which
mistakenly comes out positive and is later determined to be
inaccurate.76  The statute specifically provides that
[a] person may not bring an action for damages based on test
results. . . unless the employer’s action was based on a false
positive test result and the employer knew or clearly should have
known that the result was in error and ignored the true test
result because of reckless or malicious disregard for the truth or
wilful [sic] intent to deceive or be deceived.77
72. The statute refers to both “drug test and alcohol impairment test.”
ALASKA STAT. § 23.10.600(a).  However, this Note uses the term “drug test” to
refer to both types of testing.
73. See id.  The legal challenges may not entirely disappear, as employees will
likely attempt to challenge this statute under the public policy theory of the
covenant of good faith and fair dealing.  See supra notes 15-34 and accompanying
text (detailing legal challenges to drug testing).
74. See id. § 23.10.600(d).
75. See id. § 23.10.600(e).  This clause is set out separately from the provisions
cited supra note 73, most likely because the previous section prohibited actions for
damages, while this section refers to any actions at all.  Unfortunately, the
structure of the statute makes it difficult to determine when money damages are
prohibited and when any particular cause of action is prohibited.
76. See id. § 23.10.610.
77. Id. § 23.10.600(b).  It is unclear how an employer should have notice or
constructive notice that an employee is not a drug user in his or her private life, or
how an employee will be able to prove that his employer had such notice.  This
section effectively eliminates any actions for damages an employee might have for
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The statute also prevents an employee from bringing actions
for defamation of character, libel, slander, or damage to reputation
against an employer based on drug testing unless specific criteria
are met.  The results must be disclosed to someone unauthorized to
receive the information, the information disclosed must be a false
positive test result, the false positive must have been disclosed
negligently, and all the elements of the action, whether for
defamation of character, libel, slander, or damage to reputation,
must be satisfied.78  Because it seems negligence is involved any
time confidential information is disclosed to an unauthorized
individual, the requirement that the disclosure be made
“negligently” implies that something more than a mere disclosure
must take place.79  Employees will have difficulty proving that
information has been disclosed negligently, so most instances of
disclosed false positive results will not be actionable.  Any harm to
employers from the statute’s ambiguity in this area is mitigated by
the provision stating that in claims against employers based on
false positive test results, “there is a rebuttable presumption that
the test is valid if the employer complied with the provisions” of
the statute.80  As noted above, employers are also protected if their
reliance on a mistakenly false positive test result was reasonable
and in good faith.81
The statute provides further protection for employers from the
uncertainties of drug testing by allowing drug testing for “any job-
related purpose consistent with business necessity and the
employer’s policy.”82  The statute allows drug testing for reasons
including, but not limited to, investigation of individual
impairment; investigation of accidents; maintenance of safety for
employees, customers, clients, or the public at large; maintenance
of productivity; quality of products or services; security; or
reasonable suspicion that an employee is using drugs and that such
use adversely affects job performance or the work environment.83
As noted in the previous discussion, the only real limitation on
an employer’s action based on a false positive drug test result, since the subjective
knowledge of the employer will be nearly impossible for an employee to prove.
78. See id. § 23.10.610.
79. Id.  This lack of guidance is not only detrimental to employees seeking to
pursue a claim against an employer for breach of confidentiality in disclosing the
results of a drug test, but also leaves remnants of uncertainty for employers who
rely on the statute to protect them from litigation based on disclosures.
80. Id. § 23.10.600(c)(1).
81. See id. § 23.10.600(c)(2).
82. Id. § 23.10.620(c).
83. See id.
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private drug testing in Alaska is the employer’s willingness to pay
the costs and administrative burdens associated with performing
drug tests in accordance with the statute.
Employment actions that employers may take based on the
results of drug tests are as unlimited as the reasons for which
employers may initiate drug testing programs in the first place.84
For example, the employer can require that the employee attend
counseling or rehabilitation or be subject to suspension and
termination.85  In the case of applicants, the employer can refuse to
hire any applicant testing positive for drug use.86  In addition, the
employer may take an adverse action based on the employee’s
refusal to provide a drug testing sample.87  The statute thus
provides a plethora of protections for employers willing to incur
the financial and administrative burdens inherent in complying
with the Act.
3. Employer Burdens.  The primary burden the Act imposes
is the increased financial and administrative costs required to
comply with the law.88  Employers must pay all costs associated
with drug testing, including compensation for time taken by
employees to be tested, the costs of multiple drug tests for
employees before they can be terminated, and any additional costs
associated with on-site testing.89  Employers must also pay an MRO
to review and discuss test results with employees and to provide
substance abuse training to one designated employee.90
Furthermore, employers must bear the administrative burdens
associated with creating the written policy, complying with the
terms of the policy, and providing adequate notice of the policy to
employees.91
The intangible costs of complying with this Act include the
uncertainty created by vague portions of the Act that do not
completely reassure employers that they are shielded from
litigation.92  In addition, the statute limits an employer’s use of drug
tests to urinalysis, which is more expensive, more difficult to
84. See id. § 23.10.655(b).
85. See id. § 23.10.655(b)(1)-(3).
86. See id. § 23.10.655(b)(4).
87. See id. § 23.10.655(a)(2).
88. See supra notes 38-71 and accompanying text.
89. See id.
90. See supra notes 55-56 and accompanying text.
91. See supra notes 38-42 and accompanying text.
92. See supra notes 75, 78-83 and accompanying text.  This uncertainty could
lead to further financial costs if consultation with lawyers becomes necessary.
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administer and more intrusive than other forms of drug testing.93
The Act creates additional uncertainty by giving HHS (and for on-
site testing, the FDA) authority over Alaskan employers in testing
for drugs for which HHS has established cutoff levels, while failing
to provide what those levels are or how employers can go about
finding them.94  Thus, while offering valuable employer protections,
the Alaska Legislature has simultaneously created a series of
regulations limiting employers’ ability to conduct their drug testing
programs, and thus their businesses, as they see fit.
B. The Employee’s View of Alaska Statutes Sections 23.10.600-99
1. Employee Protections.  The primary protection afforded
employees by drug testing legislation, according to drug testing
proponents,95 is that all employees will benefit from the increased
safety and health in the workplace.  This argument assumes that
drug testing in fact improves workplace safety and health,96 and
that without this legislation employers would not test for drugs.
Yet, this legislation was motivated in part by concerns about
fairness in independent employer drug testing.  The Act therefore
benefits employees more directly by requiring that employers use
uniform, scientifically acceptable testing procedures, perform
confirmatory tests of all positive results using a more reliable
method, and have all results screened and communicated by an
MRO.97
Similarly, employees benefit from the written policy
requirements because they provide notice to employees that they
are subject to drug testing, and they specifically detail the
components of the drug testing program, including the
consequences of a positive drug test.98 The Act’s requirement that
93. See supra notes 47-49 and accompanying text.  This limitation may be a
wise one, although burdensome, because other forms of drug testing are more
controversial than urinalysis.  See Federal Workplace Drug Testing, supra note 49.
94. See supra notes 58-59 and accompanying text.
95. See Hearings, supra note 11 (noting that the Private Sector Drug-Free
Workplace Act is pro-employee because it promotes workplace safety and health,
which is “an even more significant benefit” than the increased responsibility in
employer testing).
96. While employees do benefit from safer and healthier workplaces, it is still
not clear that drug testing programs achieve such lofty goals.  The research for this
Note could uncover no study aimed directly at the amount of accidents in the
workplace before and after the institution of a drug testing program.
97. See supra notes 43-56 and accompanying text.
98. See supra notes 38-42 and accompanying text.
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the employer have a trained on-site delegate to recognize
substance abuse and determine whether reasonable suspicion exists
to require individual drug testing further protects employees
against an employer’s abuse of discretion in testing for any job-
related reason consistent with business necessity.99  Finally, the Act
protects employee interests by emphasizing the need to protect
employee privacy during testing (to the extent reasonably possible,
considering the invasive nature of urinalysis)100 and by explicitly
stating that information related to drug testing results are to be
kept confidential.101
2. Potential Problems for Employees.  Despite the statutory
protections described above, the Act does not appropriately
balance the employers’ interests with the employees’.  The primary
problem drug testing presents for employees is the invasion of
privacy necessitated by the collection of the sample and the related
disclosures required at the time of testing.102
The collection of a urine sample is the most obvious intrusion
on employee privacy.  The Alaska Legislature addressed this issue
by stating that “[s]ample collection shall be performed in a manner
that guarantees the individual’s privacy to the maximum extent
consistent with ensuring that the sample is not contaminated,
adulterated or misidentified.”103  Because this language does not
prevent an employer from using his or her discretion to require a
witness to observe collection of the urine, the provision does little
to guarantee the employee any privacy.  The collection of a urine
sample poses an additional privacy concern in that the sample
provides the employer with confidential information unrelated to
drug use.104  Indeed, a major flaw in the Act is that it contains no
99. See supra notes 84-87 and accompanying text; see also supra note 57 and
accompanying text.  It is arguable, however, whether the combined 120 minutes of
training this employee receives in drug and alcohol abuse can sufficiently protect
the employee interests.  Furthermore, this employee might still be subject to the
employer’s influence in deciding whom to individually drug test, negating any
tangible benefit to employees in serving as a check on an employer’s malicious
behavior.
100. See infra note 111-133 and accompanying text.
101. See ALASKA STAT. § 23.10.660 (LEXIS 1998).  The protection afforded
employees by this provision is limited by the lack of language indicating that
breaches of confidentiality will result in a loss of the protections of the act.  See
infra notes 117-127 and accompanying text.
102. See ALASKA STAT. §§ 23.10.630-40.
103. ALASKA STAT. § 23.10.630(c).
104. An employer could test a urine sample to determine if an employee were
pregnant, or had AIDS or diabetes, for example.
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provision prohibiting employers from testing the samples for other
conditions or use of substances other than illegal drugs.105
Although employers may be discouraged from testing for these
additional conditions by the ADA,106 and because of the added
expense such tests would entail, the Alaska Legislature should
have required employers seeking the protection of the Act to
refrain from testing for other conditions or for substances besides
illegal drugs.  Such a provision would have provided Alaska
employees with vital protection of their state constitutional right to
privacy,107 while only slightly restraining the actions of employers.108
The Act should also provide protection against such action by
allowing employees recourse to either internal grievance
procedures109 or the courts (as the ADA might require)110 if the
employer does test the sample for substances or conditions other
than illegal drug use.
Requiring an employee to submit to drug testing necessarily
entails the disclosure of current medical conditions and
identification of any current or recently used prescription or non-
prescription drugs.  As such, the mandated testing is a further
invasion of employee privacy.111  The statute requires the employee
to have the opportunity to provide this information to the MRO or
to the person collecting the sample, and does not directly require it
to be given to the employer.  However, it is not clear from the
105. See ALASKA STAT. §§ 23.10.600-99. Cf. ARIZ. REV. STAT. § 23-493.09
(1998).
106. See 42 U.S.C. § 12112(a).  An adverse employment action taken on the
basis of a medical condition discovered through a drug testing sample would be
discrimination on the basis of a disability, in violation of the statute; see also supra
notes 32-34 and accompanying text.
107. See ALASKA CONST. art. I, § 22; see also supra notes 15-21 and
accompanying text.
108. The only employer action restrained would be the unethical action of
testing an employee’s sample for conditions and substances other than illegal
drugs.
109. A provision mandating employers to set up grievance procedures to deal
with drug testing issues would be a valuable compromise for both sides.
Employees would be able to have their grievances with the drug testing program
heard and perhaps rectified, and employers would still avoid expensive litigation.
110. To truly protect an employee’s vital privacy right, employees should have
a private right of action against employers who breach their privacy in such a
grievous manner, aside from an action under the ADA.
111. See ALASKA STAT. § 23.10.640(a) (LEXIS 1998).
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statute whether the employer will have access to this information.112
Although employees may decline to provide this information, they
will be denied the benefit of having the test result reported as
negative if the medication they are using may have caused the
positive result.113  This condition unfairly places employees in the
position of having to choose to keep their medical information
private, risking a positive result based on a medical condition or
prescription drug, or to disclose private information that might
indirectly be shared with the employer.  Such private information
could then be used by the employer to justify an adverse
employment action, leaving the employee with no recourse to
internal grievance procedures or the courts.114  Moreover, placing
employees in this compromising position is further objectionable
when on-site urinalysis is conducted by a delegate of the
employer.115  Employees would then be forced to provide
confidential information to the delegate, a fellow employee, in
order to account for a possible positive test result caused by the use
of prescription medication or a medical condition.  Such a
procedure is a further unwarranted intrusion into employees’
private lives.116
Although section 23.10.660 specifically deals with confidential
information, this section, like the rest of the Act, lacks any practical
recourse for employees who suffer a breach of confidentiality by
their employers.117  This provision states that “a communication
received by an employer relevant to drug test or alcohol
impairment test results and received through the employer’s testing
program is a confidential and privileged communication and may
not be disclosed”118 except to listed individuals, including courts or
governmental agencies.119  However, the statute does not specify
112. See id. (indicating only that “the person collecting the sample . . . provide
the person to be tested with an opportunity to provide medical information that
may be relevant to the test”).
113. See id. § 23.10.640(d)(3) (requiring the physician reviewing the test results
to “report test results that have been caused by prescription medication as
negative”).
114. For example, an employer could discharge an employee who disclosed
prior to a drug test the use of drugs to treat HIV.
115. See id. §§ 23.10.645-50.
116. See id.  There is little left of the “confidentiality” mandated by the statute
when an employee must disclose information not only to a worker at an
independent lab, or to the employer, but also to a fellow worker whom that
employee must face, and in some cases, supervises the employee.
117. See id. § 23.10.660; see also supra notes 67-68 and accompanying text.
118. ALASKA STAT. § 23.10.660.
119. See id.
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the consequences for employers who violate this provision.120
While employers should be subject to litigation in the event of a
breach of confidentiality, section 23.10.610, which limits causes of
action for disclosures, negates this possibility.121  It bars actions for
defamation of character, libel, slander, or damage to reputation
except when related to a negligently disclosed false positive test
result.122  The language of the statute indicates that causes of action
for any other disclosure will not be allowed, even though such a
disclosure necessarily entails violation of the confidentiality
mandated in section 23.l0.660.123  By removing legal remedies for
these violations of employee privacy, the Alaska Legislature has
left employees to rely on their employer’s good faith that drug
testing samples will be used appropriately.  Without recourse to the
courts124 or even a provision requiring an internal grievance
procedure for drug testing violations,125 the provision mandating
confidentiality of employee information is meaningless.
The statute also leaves employees vulnerable to the threat of
criminal action, since even confidential communications may be
disclosed when ordered by a court or governmental agency.126  The
Legislature could have provided employees with stronger
protection (and stronger incentive for submitting to the test rather
than risking termination for a refusal to submit) by preventing the
test results from being used in any court actions except those
directly based on the results of the test.127  This provision would
have provided important protections for employees required to
submit to drug testing as a prerequisite to employment, and it
would have had no effect on the protections afforded the
employers.  In fact, a provision limiting the use of test results in
other court actions would aid employers by keeping them out of
litigation unrelated to their businesses, such as for testimony
relating to the prosecution of a former employee on drug charges.
Additionally, because the Act allows employers to perform
random, suspicionless drug testing, as well as testing of individuals
120. See id; see also supra notes 67-68 and accompanying text.
121. See ALASKA STAT. § 23.10.610.
122. See id; see also supra notes 76-81.
123. See id. §§ 23.10.610, 23.10.660.
124. See supra note 109.
125. See supra note 110.
126. See ALASKA STAT. § 23.10.660(3).
127. Other legislatures have provided stronger protections.  See ARIZ. REV.
STAT. § 23-493-09 (1998); UTAH CODE ANN. § 34-38-13 (1998); see also infra notes
132-153 and accompanying text.
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suspected of impairment,128 unscrupulous employers may abuse
their authority to harm particular employees.  The employer could
use confidential drug testing information to subject employees to
criminal drug prosecution, to jeopardize an employee involved in a
child custody dispute, or to threaten the employee’s ability to
obtain other employment.129  Because the statute does not require
company management to be tested along with employees,130 the
threat of abuse of discretion by employers is even greater.
Employers have nothing to lose in this drug war, aside from the
costs of testing.  Employees, however, must simply accept their
employers’ word that they will keep medical and drug use
information confidential, and that they will not intervene in their
employees’ other private affairs by offering drug test results to
courts and governmental agencies.  Employees are being asked by
the Alaska Legislature to rely far too much on an employer’s good
faith.  The Legislature could have balanced the employers’ and
employees’ interests better by enacting a few additional protections
for employees — without causing harm to employer interests.131
IV.  OTHER DRUG TESTING LEGISLATION
Other states’ statutes with the same goals of regulating the use
of drug testing in the employment context balance the parties’
interests more equitably.  Arizona’s and Utah’s statutes were based
on the President’s Commission on Model State Drug Laws, as was
Alaska’s, but the Alaska statute neglected to adopt some of the
core provisions protecting employees that the Arizona and Utah
statutes include.132  The Alaska statute is also lacking in many
respects when compared with similar federal statutes, both
proposed and enacted.  This section of the Note will compare the
core provisions of other state and federal drug testing statutes with
those enacted in Alaska.
128. See ALASKA STAT. § 23.10.620(c).
129. While the Act prohibits such voluntary disclosures by employers, the lack
of sanctions for unauthorized disclosures leaves unscrupulous employers little
reason to abide by this prohibition.
130. Other legislatures have required equal treatment of company
management.  See infra notes 140, 145 and accompanying text.
131. Again, other legislatures and lawmakers have seen fit to add such
protections.  See infra notes 133-153 and accompanying text.
132. See Hearings, supra note 35 (noting that the Private Sector Drug-Free
Workplace Act embraces “concepts of the legislation endorsed by the President’s
Commission on Model State Drug Laws . . . . and enacted into law in Alaska,
Arizona, Idaho and Utah”).
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A. The States: Utah and Arizona Drug Testing Statutes
Both the Utah “Drug and Alcohol Testing” statute,133 enacted
in 1987, and the Arizona “Drug Testing of Employees” statute,134
enacted in 1994, contain language substantially similar to the
Alaska Act.135  However, the Utah and Arizona statutes are more
clearly organized than the Alaska Act, and, in many instances, use
clearer language.136  The most significant difference is that the
Alaska Act is lacking in some of the core employee protection
provisions available in the other acts.
The Utah statute makes clear at the outset that the statute is
not intended to prohibit any employee from seeking damages or
job reinstatement for actions taken based on false drug test
results.137  However, much like the Alaska Act, monetary damages
are not available if the employer’s reliance on the false test result
was reasonable and in good faith.138  It is not clear whether Alaskan
employees may similarly seek job reinstatement.  The Alaska
statute, which also limits damages, including monetary damages,
does not refer to job reinstatement at all.139  The Utah statute also
extends to employees an intangible protection by requiring
“[e]mployers and management in general” to submit to the testing
themselves “[o]n a periodic basis.”140  This requirement creates a
presumption that the tests will be administered fairly.
The final significant difference between the Utah statute and
the Alaska statute is that the Utah statute explicitly states that all
information, interviews, reports, statements, memoranda, or test
results are confidential.141  Such information “may not be used or
received in evidence, obtained in discovery, or disclosed in any
public or private proceeding” except those relating to an adverse
employment action taken by an employer under the statute.142  The
133. See UTAH CODE ANN. §§ 34-38-1 to 15 (1998).
134. See ARIZ. REV. STAT. §§ 23-493.01 to 11 (1998).
135. See ALASKA STAT. §§ 23.10.600-99 (LEXIS 1998).
136. See id. § 23.10.600.  Cf. ARIZ. REV. STAT. §§ 23-493.06 to 07; UTAH CODE
ANN. §§ 34-38-9 to 11.  The Arizona and Utah statutes are better organized as a
whole because they begin with purposes and findings, then indicate testing
procedures, followed by the protection from litigation sections.  This makes better
intuitive sense than Alaska’s organization, which begins with litigation limitations,
then the testing procedures, and lacks a purposes or findings section.
137. See UTAH CODE ANN. § 34-38-1.
138. See id. § 34-38-10.
139. See ALASKA STAT. § 23.10.600-10.
140. UTAH CODE ANN. § 34-38-3.
141. See id. § 34-38-13(1).
142. Id.
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Utah Legislature wisely recognized that inclusion of this provision
provides a crucial protection to employees, while it in no way limits
the rights of the employer.  The Utah Legislature also provided
protection to the employer by indicating that the employer may not
be called as a witness under the Act unless the employer’s adverse
employment action precipitates the proceeding.143  The Utah
Legislature ensured that the drug testing encouraged by the statute
would serve its purpose of decreasing workplace problems, rather
than negatively affecting the employment relationship.
The Arizona Legislature provided many of the same
protections offered by the Utah Legislature.144  The Arizona
statute, like the Utah statute, requires that “all compensated
employees including officers, directors and supervisors shall be
uniformly included in the testing policy.”145  The Arizona
Legislature also made confidential all communications relevant to
drug test results.  Such status requires that they not be used as
evidence, obtained in discovery, or disclosed in any proceeding
except one related to an adverse employment action taken by an
employer under the drug testing statute.146  The Arizona
Legislature went even further in protecting employee privacy by
adding the provision that “[e]xcept as otherwise permitted by law,
no sample taken for testing pursuant to this article shall be tested
for any substance or condition except unlawful drugs or alcohol.”147
This provision prevents a further invasion of privacy after a sample
has been collected for drug testing — the threat that the employer
may learn an employee’s confidential medical information,
information that the employee may not even yet be aware of in
some cases.148  Although the ADA may prohibit such conduct on
the part of employers,149 and employers may find it “expensive and
unnecessary” to conduct extra testing of employee samples,150  a
provision prohibiting such conduct is still necessary and desirable
143. See id. § 34-38-13(4).
144. See ARIZ. REV. STAT. §§ 23-493.01 to 11 (1998).  Cf. ALASKA STAT. §§
23.10.600-99; UTAH CODE ANN. §§ 34-38-1 to 15.
145. ARIZ. REV. STAT. § 23-493.04.
146. See id. § 23-493.09(A).
147. Id. § 23-493.09(C).
148. See id.; see also supra note 104.
149. See supra notes 32-34 and accompanying text.
150. Testimony given in relation to the Drug Free Workplace Act of 1998 is
instructive here, as it applies equally to state legislation on drug testing.  See H.R.
584, 105th Cong. (1998) (codified in 15 U.S.C. § 654 (1999)) (“Several of the
employer witnesses testified [before the House] that they do not and would not
test beyond drugs and alcohol.  Such testing is expensive and unnecessary.”).
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to provide additional assurance that this privacy violation will not
occur.
While both the Utah and the Arizona statutes protect
employee privacy more than the Alaska statute, both statutes still
fail to enact legislation that offers the fairest compromise between
the privacy rights of employers and employees.  Both statutes
protect the confidentiality of drug testing information through
explicit provisions, but fail to provide any recourse for employees
who suffer a breach of confidentiality.151  Because each statute
requires employers to refrain from disclosing confidential
information, they should also provide the victims of disclosures
some cause of action, whether through internal grievance
procedures or the legal system.  At the very least, the Legislatures
could have mandated that a breach of confidentiality relating to
drug testing forfeits the protection provided by these acts, just as
failure to follow the testing and administrative procedures forfeits
the protections of these acts.  The failure of the three state
legislatures to fully and effectively protect employee privacy rights
indicates that each failed in its goal to create legislation that
ensures “the preservation of privacy and dignity”152 of employees
and “fair and equitable testing for drugs and alcohol in the
workplace.”153
B. The Federal Government: The Drug-Free Workplace Act of
1998 and the Private Sector Drug-Free Workplace Act
The Drug-Free Workplace Act of 1998154 (the “1998 Act”) is
the small business counterpart to the Drug-Free Workplace Act of
1988155 (the “1988 Act”), which required implementation of drug-
free awareness programs for federal contractors and grant
recipients.  The 1998 Act differs from the 1988 Act in that it
earmarks $10 million for the Small Business Administration for
grants to contract with not-for-profit organizations in order to
provide small businesses with drug-free workplace programs.156
The 1998 Act goes further than the 1988 Act, requiring such
programs to include a written policy prohibiting certain substances
in the workplace, two hours of substance abuse training for
employees, additional training for employees who are parents,
151. See ARIZ. REV. STAT. § 23-493.09; UTAH CODE ANN. § 34-38-13 (1998).
152. 1994 Ariz. Legis. Serv. 246, § 1 (West).
153. UTAH CODE ANN. § 34-38-1.
154. See H.R. 105-584.
155. See 41 U.S.C. §§ 701-707.
156. See H.R. 105-584.
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employee access to an employee assistance program, and employee
drug testing.157  The 1998 Act mandates that small business
employers administer drug tests through a laboratory approved by
the HHS, and that positive results be confirmed and reviewed by
an MRO.158  Because the 1988 Act does not make any reference to
drug testing,159 the 1998 Act marks the first time Congress has
indicated, on a federal level, that employers may request federal
funds for the purpose of instituting drug testing programs in private
workplaces.160  Although compliance with this statute is voluntary,
businesses that decide to comply must provide the entire range of
programs mandated in the statute, restricting the ability of small
businesses “to tailor a program that meets their needs.”161
While the House Committee on Small Business adopted this
statute, the minority views of committee Democrats indicated that
the 1998 Act, like the Alaskan drug testing statute, “still sorely
lacks employee protections.”162  Additionally, the minority
committee members recognized that the bill contains no clear
procedural guidelines for handling situations where employees test
positive or voluntarily come forward with drug abuse problems.163
The minority committee members further indicated that the testing
provisions were “extremely vague,” allowing for “controversial
methods of testing [such] as hair samples,” which “will not foster a
drug-free work place, but create an environment filled with tension
and uncertainty between employees and supervisors.”164  The
Alaska Legislature, unlike the federal government (or the Utah or
Arizona Legislatures), wisely avoids the controversial use of hair,
sweat or saliva testing.165  However, the Alaska statute still helps to
foster the tension-filled environment the minority committee
members warned against by not testing supervisors and others in
157. See id.
158. See id.
159. See 41 U.S.C. §§ 701-707 (1998); see also Parker v. Atlanta Gas & Light
Co., 818 F. Supp. 345 (S.D. Ga. 1993) (noting that the Drug-Free Workplace Act
did not mandate drug tests).
160. See H.R. 105-584.
161. Id. (minority views).
162. Id.
163. See id.
164. Id.
165. See ALASKA STAT. § 23.10.699 (LEXIS 1998) (defining “sample” to
include only breath or urine).  Cf. ARIZ. REV. STAT. § 23-493 (1998) (defining
“sample” to include urine, blood, breath, saliva, hair or other substances from the
person being tested); UTAH CODE ANN. § 34-38-2 (1998) (defining “sample” to
include urine, blood, breath, saliva or hair).
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active control of the business.166  The 1998 Act, in contrast, defines
“employee” to include supervisors, managers, and owners and
officers active in management of the business, so that these
individuals must be drug tested as well, which lessens the tension
the Act creates in the work environment.167  The enacted version of
the 1998 Act better protects employee privacy than the Alaska Act
by prohibiting the mandatory disclosure of medical information by
an employee prior to a confirmed positive test, and requires that
the MRO only report “final results, limited to those drugs for
which the employee tests positive.”168
The Act contains more detail on drug testing procedures than
the Drug-Free Workplace Act of 1998.  This greater detail results
in stronger protection for employees from unfair testing
procedures.  However, the Act suffers from vagueness in the
provisions limiting the tort rights of employees.169  From the
language of the statute it is not clear what remedies employees
whose rights are violated by drug testing may seek, or if they are
simply barred from pursuing any cause of action related to drug
testing.170
The proposed Private Sector Drug-Free Workplace Act171 (the
“Proposed Act”), if passed, would be the federal counterpart to the
Act.  The statute would, in fact, preempt the Alaska statute,
subjecting Alaskan employers to the will of the federal government
on this issue.172  The Proposed Act would also preempt any other
federal or state law
that applies to the hiring, employment, continued employment
or reemployment in a sensitive position of a drug addict,
recovering drug addict, drug abuser, alcoholic, recovering
alcoholic, or alcohol abuser, or to the reinstatement or rehiring
of any employee in a safety-sensitive position . . . that has
produced a confirmed “positive” [drug- or alcohol-test] result.173
166. See ALASKA STAT. § 23.10.699 (defining “employee” as a person in the
service of an employer).  One could argue based on this definition that a
supervisor is in the service of an employer; however, an owner/manager would not
be.  The Alaska Legislature should clarify this ambiguity with an explicit provision
regarding supervisors, owners, and officers.
167. See H.R. 105-584.
168.  15 U.S.C. 654(c)(2)-(3) (1999).
169. See ALASKA STAT. §§ 23.10.600-10.
170. See id; see also supra, notes 72-81, 121-125 and accompanying text
(detailing ambiguities in litigation limitation sections).
171. See de Bernardo, supra note 35.
172. See id.
173. Id.
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This provision may eliminate the ADA as a source of protection
for recovering substance abusers who are refused jobs based on
stereotypes about the abilities of recovering substance abusers.174
The provision may also eliminate use of the ADA to prevent
employees from revealing private medical information in relation
to drug tests.175  At the same time, state legislatures would be
barred from preventing drug testing, despite legitimate concerns
that state legislatures might have about the unreliability and
invasion of privacy inherent in such methods of detecting drug
users.  State lawmakers would be denied the opportunity to set the
laws of their states according to the values of the people who reside
there, and would be prevented from limiting drug testing according
to the needs of its employer community.  For example, since the
Proposed Act defines “sample” as “any sample of the human body
capable of revealing the presence of alcohol or other drugs or their
metabolites,”176 the Alaska Legislature would be forced to tolerate
federal protection to employers who use hair testing, despite its
judgment that such testing has not proved reliable or appropriate
for Alaskan employers.177
Despite the many drawbacks of the Proposed Act, it does
provide an immeasurably valuable protection to employees that is
absent from the Alaska, Utah, or Arizona statutes.  The Proposed
Act explicitly sets out the employer’s responsibility to adhere to all
its terms in order to retain its protections: “The employer’s use and
disposition of all drug or alcohol test results are subject to the
limitations of this Title if the employer is to qualify for the legal
174. This is a concern especially when considering section 10 of the proposed
Act, which would permanently exclude those who test positive for drugs from
employment in broadly defined “safety-sensitive” positions.  See id.  Another
proposed statute, the Public and Employee Safety Assurance Act, also presented
to Congress during the testimony of Mr. de Bernardo, would allow employers to
exclude both those who test positive for drugs and those “with a history of
substance abuse” (also broadly defined) from employment in the same broadly
defined “safety-sensitive” positions.  See id.  This could violate the ADA, were it
not for similar preemption language in that statute.
175. See Roe v. Cheyenne Mountain Conference Resort, 124 F.3d 1221 (10th
Cir. 1997) (successfully challenging under the ADA required disclosures of
confidential medical information in relation to an employer’s drug testing
program); see also supra notes 32-34 and accompanying text.
176. de Bernardo, supra note 35.
177. See ALASKA STAT. § 23.10.699 (LEXIS 1998).  Assuming, in the absence of
legislative history, that if the legislature had found hair, saliva, or sweat testing
methods reliable or appropriate, it would have altered the definition of “sample”
to include those methods.
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benefits and protections available under this Title.”178  Among
other things, this provision provides an incentive for employers to
retain confidentiality of information relevant to drug testing.  The
Act also prohibits, in language identical to that in the Utah and
Arizona statutes, the use of drug test results in evidence, and
disclosure during discovery or in any public or private proceeding
except that related to an adverse employment action taken by an
employer under the Proposed Act.179  With these several provisions,
the federal drug testing statute manages to provide a much better
balance of employer interests with the privacy right of employees.180
V.  POLITICS, POLICY, AND CONCLUSIONS
In 1982 President Ronald Reagan initiated the War on Drugs,
commenting in a radio address that “We’re making no excuses for
drugs — hard, soft, or otherwise.  Drugs are bad and we’re going
after them.”181  Thus, drugs, and the fight against them, rapidly
became America’s prime political obsession, both for politicians
and many voters.  The fundamental problem with drug fighting as a
political issue is that “tough on crime” sentiments such as President
Reagan’s often preclude rational debate on drug policy.  Most
critical examination of the extent of the drug problem in the
United States was conducted by government-sponsored
commissions or task forces, which had an admitted agenda to “go
after” drugs.182  Thus, there has been an extreme lack of reliable,
unbiased information on drug use.  This unreliability stems from a
refusal to identify the governmental source of much of the
information on drug use available to the public, a failure to define
the terms used in reporting results of surveys, the failure to explain
178. de Bernardo, supra note 35.
179. See id.
180. See id.
181. Steven Wisotsky, Crackdown: The Emerging “Drug Exception” to the Bill
of Rights, 38 HASTINGS L.J. 889, 890 (1987) (quoting the President’s Radio
Address to the Nation, 18 WEEKLY COMP. PRES. DOC. 1249 (Oct. 2, 1982)); see
also Staci O. Schorgly, Note, Sacrificing the Fourth Amendment in the Name of
Drugs: State v. Damask, 66 UMKC L. REV. 707 (1998).
182. Id.; see also DAN BAUM, SMOKE AND MIRRORS: THE WAR ON DRUGS AND
THE POLITICS OF FAILURE 199, 119-21 (June 1997) (noting that former drug czars
under President Reagan believed drug agencies “should promote the ideas of the
people who paid them:  the administration in power”) (also noting the
partnerships of independent parent-drug information organizations with federal
drug policymakers under the Reagan administration).
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the conditions under which such surveys were produced, and the
failure to distinguish among various drugs.183
One potent example of this phenomenon in the drug testing
arena is a widely quoted statistic indicating the “costs” of drug
abuse to the American workforce.  In 1998, this figure was cited as
$60 billion by an Ohio Representative,184 and increased to $75
billion when Mr. Mark de Bernardo, the Executive Director of the
Institute for a Drug-Free Workplace, testified before the House of
Representatives.185  The Alaska Supreme Court, writing in 1989 in
Luedtke v. Nabors Alaska Drilling,186 cited the figure as between
“$60 billion and $100 billion per year”187 and noted that a 1988
survey put the cost at more than $100 billion per year.188  A survey
on the National Institute for Drug Abuse’s Internet web site
indicated that 1995 estimates for the economic effects of drug
abuse are $109.8 billion.189  None of the sources citing this elusive
statistic, not even the Luedtke court’s opinion,190 contained any
further indication of what study this figure was derived from or
how these costs were determined.  Also lacking in this statistic is
important information about what exactly was studied, under what
conditions the study was conducted, and which drugs were involved
183. See id.
184. See Lisa Finnegan, Crack Down on Drugs, OCCUPATIONAL HAZARDS,
September 1, 1998, available in 1998 WL 15157543 (1998).  Finnegan states,
“[Representative] Portman [R-Ohio] said illegal drug abuse costs American
businesses more than $60 billion every year in managed claims, accident costs, and
lost productivity.”  Id.
185. See de Bernardo, supra note 35.
186. 768 P.2d 1123.
187. Id. at 1139 (Matthews, C.J., concurring) (citing Richard N. Cook, Note,
Drug Testing of Public and Private Employees in Alaska, 5 ALASKA L. REV. 133,
133 (1988)).
188. See id. (citing N.Y. TIMES, Dec. 12, 1988 (Business Section), at 1).
189. The NIDA study calculated this figure by using 1992 estimates and
projecting them upward for increased population growth and price changes,
without considering the incidence and prevalence of alcohol and drug problems
during the period from 1992 to 1995.  One wonders what purpose this statistic
serves when it fails to indicate whether it considers drug and alcohol problems in
the workplace in addition to general problems arising from drug and alcohol
abuse.  It is also remarkable that from 1988 to 1998, the estimated costs of drug
abuse to American business could fluctuate from $100 billion, to $75 billion, and
back up to $109 billion.
190. The court cites to Cook, supra note 187, which in turn cites to Castro,
Battling Drugs on the Job, TIME, Jan. 27, 1986, at 43.  This article cites to “a study
released by the Research Triangle Institute in June 1984,” presumably the same
study sponsored and published by the NIDA, supra note 189.  Id.
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in the study — all crucial to understanding what is at stake in the
fight against illegal drugs.
Not only is this statistic uninformative, but upon further
examination, it is revealed to have a dubious scientific basis.191  An
article by John Horgan in the New Republic provides the following
insight:
In 1982, the NIDA [National Institute on Drug Abuse] surveyed
3,700 households around the country.  The Research Triangle
Institute (RTI), a NIDA contractor in North Carolina, then
analyzed the data and found that the household income of adults
who had ever smoked marijuana daily for a month (or at least
twenty out of thirty days) was twenty-eight percent less than the
income of those who hadn’t.  The RTI analysts called this
difference “reduced productivity due to daily marijuana use.”
They calculated the total “loss” when extrapolated to the general
population, at $26 billion.  Adding the estimated costs of drug-
related crimes, accidents, and medical care produced a grand
total of $47 billion for “costs to society of drug abuse.”
Several things are wrong here, but the most glaring error is the
simpleminded conclusion that marijuana smoking caused the
lower incomes with which it was associated [since] mere
correlation never establishes causality.192
This study is scientifically faulty because it rests on the mere
correlation of ever having used marijuana regularly and lower
income.  It is too narrowly focused on marijuana to justify its
application to all drugs, and it also is not clear that an appropriate
cross section of society was in the sample.  Even if an appropriate
sample of American households were surveyed, there is not even a
single glance into the nation’s workplaces to determine what the
actual costs of drug abuse are, even though this statistic has been
used to convey the cost of drug abuse to American businesses.  The
researchers involved with the study apparently recognized the
limitations of their study, because they noted
[e]stimates from this study are generally comparable to those
produced by prior major studies on the economic impact of drug
and alcohol abuse.  Although literally hundreds of differences
have occurred from study to study[,] . . .  it is fair to say that
generally similar methodological approaches have been
applied. . . . The major cause of variation across the five studies
is reduced productivity.193
191. See John Horgan, Your Analysis is Faulty (How to Lie with Drug
Statistics), THE NEW REPUBLIC,  Apr. 2, 1990.
192. Id.  (emphasis added); see also Baum, supra note 180, at 230-31.
193. National Institute on Drug Abuse, The Economic Costs of Alcohol and
Drug Abuse in the United State – 1992 (visited Oct. 28, 1999)
<http://www.nida.nih.gov/EconomicCosts/Chapter 1.html> (emphasis added).
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In the “Impaired Productivity” section of the study, the researchers
recognized that
[a]n estimated $82 billion in lost potential productivity was
attributed to alcohol and drug abuse in 1992  ($67.7 billion and
$14.2 billion, respectively).  This accrued in the form of work not
performed — including household tasks — and was measured in
terms of lost earnings and household productivity.  These costs
were primarily borne by the drug or alcohol abusers and by those
with whom they lived. . . . This study has not attempted to estimate
the burden of drug and alcohol problems on work sites or
employers, nor should the estimates in this study be interpreted in
this manner.194
It is not clear why impaired productivity is factored into the
estimates for costs to employers for drug abuse, resulting in so
much variation among the different studies attempting to quantify
the costs of drug abuse to employers.  Further, the NIDA study
focused on costs to society, not necessarily to American employers,
and included such factors as motor vehicle crashes, premature
death, crime, social welfare, along with the elusive impaired
productivity standard.195  The only factor logically transferred to
employers is the cost of health care expenditures, approximated at
$9.9 billion, $4.4 billion of which was for specialized services for
treatment of drug problems, generally not incurred by employers.196
Thus, this study rests mainly on factors not related to employer’s
costs.197  Because those who have cited this statistic have failed to
indicate upon which study they are relying, the public has no way
to examine the studies and determine whether they are adequate
premises from which to begin a discussion of appropriate drug
policy for the nation’s workforce.  Even more distressing, with all
of the studies attempting to quantify the “costs” of drug abuse to
employers, none have attempted to look at the actual number of
194. Id. (emphasis added).
195. See id.  It is remarkable that factors indicating impaired productivity due
to drug abuse included “household tasks” as a criterion, the more so when the
figure is then used to indicate the costs to American businesses from illegal drug
abuse.
196. See id.  Many employer health insurance programs that are required to
provide mental health services are not required to provide substance abuse or
chemical dependency treatment.  See Mental Health Parity Laws by State, (visited
Nov. 2, 1999) <http://www.insure.com/health/mentalstate.html> (noting that
neither federal law nor state laws in Arizona, California, Indiana, Louisiana,
Minnesota, New Jersey, South Carolina, and Tennessee require health plans to
cover substance abuse or chemical dependency treatment).
197. See id. (noting that the other studies on the economic impact of drug and
alcohol abuse use “generally similar methodological approaches”).
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accidents in the workplace before or after a drug testing program,
not even to demonstrate a mere correlation of drug testing with
fewer accidents.198
With such inadequate information disseminated to the public
by the nation’s huge (and expensive) anti-drug campaign, it is hard
to accept at face value the need for drug testing in the workplace,
especially considering the invasion of privacy such testing
necessarily entails.199  While employment drug testing rests on
unproven grounds, it has become the norm in many of the nation’s
workplaces, from government regulated industries to retail outlets.
Until scientifically reliable studies generated by non-government
sources demonstrate an actual need for drug testing, employers
should continue to rely on their own good judgment as to whether
employees are performing at acceptable levels, instead of resorting
to drug testing.  Voters should tell their legislators to vote against
the proposed Private Sector Drug-Free Workplace Act and similar
legislation, at least until there are more reliable indicators that such
drastic limits on employees’ privacy rights are absolutely necessary
to achieve safe and effective workplaces.  We are entering the
realm Justice Marshall warned against in 1989,200 where
fundamental freedoms are sacrificed in the name of an urgent
cause, without a single reliable piece of evidence to show that the
cause is valid, or that the sacrifices are required on the basis of
anything more than stereotypes about the dangers drug abusers
present to the American workplace.
Alaska has provided yet another frontier on which the
government has played out its War on Drugs despite the state’s
reputation as “the home of people who prize their individuality and
who have chosen to settle or to continue living here in order to
achieve a measure of control over their own lifestyles which is now
virtually unattainable in many of our sister states.”201  The character
of life in Alaska is further threatened by the use of drug testing by
private employers, but there are steps that employers and
employees can take to ensure that the work environment is not
disrupted by drug testing.
Employers in dangerous industries may find drug testing the
only appropriate way to prevent accidents and increased health
insurance costs.  Those employers should not only adhere to the
198. If these studies have been conducted, they do not seem to have been
published — at least my research has revealed no publications on point.
199. See supra notes 102-131 and accompanying text.
200. See Skinner v. Railway Labor Executives’ Ass’n, 489 U.S. 602, 635 (1989)
(Marshall, J., dissenting).
201. Ravin v. State, 537 P.2d 494, 504 (Alaska 1975).
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Act, but also implement the procedures specified in the provisions
that the Legislature failed to include in the statute.  For example,
employers are encouraged to establish internal grievance
procedures for drug testing; to make it company policy not to
disclose confidential information related to drug tests, nor to test
samples for anything other than illegal drug or alcohol abuse; and
to include their supervisors, officers, and themselves, as owners, in
their drug testing policy, so that their employees will feel they are
being treated as fairly as possible.  These minor steps can ensure
that the employment relationship remains viable and productive in
the face of a drug testing program.
Employees who object to drug testing are encouraged to
exercise their rights to find employment that does not require such
tests.  This is a drastic measure, and perhaps not a feasible option
for many, but may be the best way to adequately prevent a
program that employees may find morally reprehensible.  If
employees are unable to take such a measure, they should attempt
to unite with their fellow workers in opposition to their employer’s
drug testing program to encourage their employer to drop such
programs, or to refrain from adopting them at all.  While this
stance is hardly more palatable202 than changing employment based
on drug testing, it is the next best way to voice opposition to drug
testing.  Employees should communicate their objections to an
employer’s drug testing policy, especially when changing
employment for that reason.  Should an employee feel violated by
an employer’s decision to drug test, employees should take a
proactive stance by communicating these concerns to the employer.
They should request a forum for employees to voice their concerns
prior to the adoption of a drug testing policy.  If the policy is
already in place, and an adverse circumstance arises in relation to
it, the employee should request a hearing or other form of review.
Employees should work together with their employers to create a
policy that is fair and reasonable, a policy that employers and
employees alike can live with.  With open communication and
careful decision making, Alaskan employers and employees can
heed Justice Marshall’s warning, and prevent the exigent
circumstances of the nation’s perceived drug crisis from sacrificing
the fundamental freedoms we all cherish.203
Mechelle Zarou
202. Employers and others are likely to consider that those protesting drug
testing have something to hide.
203. See Skinner, 489 U.S. at 635.
